AN2 Therapeutics
ANTX
ANTX
36 hedge funds and large institutions have $72.4M invested in AN2 Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
46% less capital invested
Capital invested by funds: $134M → $72.4M (-$61.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.45M | |
| 2 | +$1.03M | |
| 3 | +$834K | |
| 4 |
Citigroup
New York
|
+$680K |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$633K |
Top Sellers
| 1 | -$1.55M | |
| 2 | -$1.12M | |
| 3 | -$908K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$640K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$331K |